MP74 - MP74: Prostate Cancer: Localized: Surgical Therapy IV

Poster Presenter(s)

• 

  Ahmed Sayed Ahmed, MD,MSc

  Clinical Fellow
  University of Montreal Health Center, Montreal Quebec, Canada

  PDF Poster Slides and Audio
• 

  Matteo Balzarro

  AOUI Verona, Verona, Italy
• 

  Johan Björklund, MD

  Karolinska Institutet / University of Toronto

  Poster
• 

  Carlo Bravi, MD

  San Raffaele Hospital

  PDF Poster Slides and Audio
• 

  Daniel Costa, MD

  Associate Professor
  University of Texas Southwestern Medical Center

  PDF Poster Slides and Audio
• MD

  Mohammad Durrani, BS

  Roswell Park Comprehensive Cancer Center

  PDF Poster Slides and Audio
• 

  Giorgio Gandaglia

  Department of Urology, San Raffaele Hospital

  PDF Poster Slides and Audio
• 

  Sanchia Goonewardene, MBCHB BMedSc Dip.SSc. MRCS UK MPhil

  Norfolk and Norwich University Hospital

  PDF Poster Slides and Audio
• JJ

  Joseph John, MD

  PDF Poster Slides and Audio
• JK

  Jung Kwon Kim
• SK

  Sophie Knipper, MD
• YK

  Yasuo Kohjimoto
• AK

  Alexander Kretschmer
• DL

  Donghyun Lee
• 

  Ivan Lysenko, MD

  Medical University of Vienna

  PDF Poster Slides and Audio
• 

  Christopher Murphy, DO

  Fellow
  OhioHealth Dublin Methodist Hospital

  PDF Poster Slides and Audio
• 

  Shintaro Narita, MD, PhD

  Akita Univerisisty School of Medicine

  PDF Poster Slides and Audio
• 

  Lova Sun, MD

  University of Pennsylvania

  PDF Poster Slides and Audio
• CW

  Clark Wilson, MD

  PDF Poster Slides and Audio
• CY

  Chang Hee Ye

Presentations:

• 7:00 AM – 9:00 AM

  MP74-01: Multiparametric Prostate MRI Structured Report Informs Preoperatively of Risk for Positive Apical Surgical Margins During Radical Prostatectomy
  Daniel N. Costa, MD – UT Southwestern Medical Center
• 7:00 AM – 9:00 AM

  MP74-02: Long-term outcomes of clinically node-positive prostate cancer patients treated with radical prostatectomy as part of a multimodal treatment: patterns of recurrence and impact on competing-risk mortality
  Giorgio Gandaglia
• 7:00 AM – 9:00 AM

  MP74-03: Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-Analysis.
  Ivan Lysenko, MD
• 7:00 AM – 9:00 AM

  MP74-04: Radical prostatectomy for Gleason 3+3 prostate cancer; who, how and why? Analysis of the British Association of Urological Surgeons complex operations database.
  Joseph Byron John, MD – Royal Devon and Exeter NHS Foundation Trust
• 7:00 AM – 9:00 AM

  MP74-05: Outcomes of neoadjuvant chemohormonal therapy with complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in patients with high-risk localized prostate cancer: A propensity-score matching analysis
  Shintaro Narita, MD, PhD
• 7:00 AM – 9:00 AM

  MP74-06: 90-day cause-specific mortality after radical prostatectomy. Nationwide population-based Swedish registry study.
  Johan K. Björklund, MD
• 7:00 AM – 9:00 AM

  MP74-07: Impact of Median Lobes on Urinary Function after Robotic Radical Prostatectomy
  Christopher R. Murphy, DO
• 7:00 AM – 9:00 AM

  MP74-08: Outpatient Experience with Extraperitoneal Single-Port Robotic Radical Prostatectomy
  Clark A. Wilson, MD
• 7:00 AM – 9:00 AM

  MP74-09: A prospective, randomized, phase 3 trial assessing the impact of early dorsal venous complex ligation on urinary continence recovery after robot-assisted radical prostatectomy. Results of an interim analysis on early post-operative outcomes
  Carlo Bravi, MD
• 7:00 AM – 9:00 AM

  MP74-10: Intraoperative measurements of urethral length and bladder neck diameter as predictors of urinary continence after robot-assisted radical prostatectomy
  Yasuo Kohjimoto
• 7:00 AM – 9:00 AM

  MP74-11: FEASIBILITY AND RELIABILITY OF TELEPHONE FOLLOW-UP AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER
  Matteo Balzarro
• 7:00 AM – 9:00 AM

  MP74-12: Thromboembolic events after radical prostatectomy in patients with hereditary thrombophilia due to factor V Leiden
  Sophie Knipper, MD
• 7:00 AM – 9:00 AM

  MP74-13: Evaluation of the tumor volume from surgical specimens after radical prostatectomy and its clinical impact on the prognosis of patients with localized prostate cancer
  Chang Hee Ye
• 7:00 AM – 9:00 AM

  MP74-14: Health-related quality of life after open and robot-assisted radical prostatectomy: A propensity score matched analysis.
  Alexander Kretschmer
• 7:00 AM – 9:00 AM

  MP74-15: Optimizing the Financial Burden of Robot-Assisted Radical Prostatectomy
  Mohammad Durrani, BS
• 7:00 AM – 9:00 AM

  MP74-16: Validation of the European Association of Urology Biochemical Recurrence Risk Groups After Radical Prostatectomy in an Asian Cohort and Suggestions for Refinement
  Donghyun Lee
• 7:00 AM – 9:00 AM

  MP74-17: A new MOdel of care for men with emotional and sexual concerns after robotic surgery for prostate Cancer (MOCA)- a feasibility study of patient reported outcome measures
  Sanchia Goonewardene, MBCHB BMedSc Dip.SSc. MRCS UK MPhil
• 7:00 AM – 9:00 AM

  MP74-18: Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years' experience from a large Canadian Academic Center
  Ahmed Sayed Zakaria Ahmed, MD,MSc
• 7:00 AM – 9:00 AM

  MP74-19: Unpredicted seminal vesicle invasion in pathological stage T3b prostate cancer: prognostic value of multi-parametric magnetic resonance imaging
  Jung Kwon Kim
• 7:00 AM – 9:00 AM

  MP74-20: Rates, determinants, and outcomes of prostatectomy in prostate cancer (PCa) patients with node positive disease
  Lova Sun, MD